News

Welcome to the CLINUVEL News page. Discover the latest in clinical, corporate, and regulatory updates.

Media Release – Second Afamelanotide Formulation

Clinical.News.Regulatory

13.07.2020

PRÉNUMBRA® – New Liquid Afamelanotide Presentation

2020 Announcements . Clinical

13.07.2020

Lapse and Forfeit of Unlisted Conditional Performance Rights

2020 Announcements . Corporate

08.07.2020

Presentation Jefferies Global Healthcare Conference

2020 Announcements . Presentation

05.06.2020

Appendix 3B and Appendix 3Y Withdrawn

2020 Announcements

25.02.2020

CLINUVEL Expands Singapore Laboratories

2020 Announcements . News

24.02.2020

Request for FDA Guidance Meeting SCENESSE® in Vitiligo

2020 Announcements . Clinical

10.02.2020

Australian TGA commences SCENESSE® review

2020 Announcements . Clinical

03.02.2020

Appendix 4C

2020 Announcements . Corporate . Financial

31.01.2020

CLINUVEL Kommuniqué I

2020 Announcements . Corporate

29.01.2020

CLINUVEL Newsletter

2020 Announcements . Corporate

16.01.2020

SCENESSE® registration dossier submitted in Australia

2019 Announcements

23.12.2019

Notice of Change of Interests of Substantial Holder

2019 Announcements

10.12.2019

.

Go To Top